MAYO CLINIC ROCHESTER
Life-space, isolation, and functional exposome study in preclinical Alzheimer's disease and cognitive environments (LIFESPACE)
Life-space, isolation, and functional exposome study in preclinical Alzheimer's disease and cognitive environments (LIFESPACE) is a funding opportunity from MAYO CLINIC ROCHESTER, up to 576175, closing February 28, 2030.
Feb 28, 2030
(1308d left)Overview
PROJECT SUMMARY/ABSTRACT Alzheimer’s disease (AD) is a global public health priority as nearly 55 million of the world’s population live with dementia, with cases projected to triple to 150 million by 2050. Dementia prevalence varies across populations, and differences are due to complex relationships across…